Therefore, GARP might be an early prognostic biomarker because it is specifically expressed on the surface of tumor-infiltrating Tregs, and lung cancer patients with early stage had more GARP+ Tregs than advanced cancer patients. This evidence concerns the gene LRRC32 and lung cancer.